BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26241940)

  • 1. MKL1 is an epigenetic modulator of TGF-β induced fibrogenesis.
    Fan Z; Hao C; Li M; Dai X; Qin H; Li J; Xu H; Wu X; Zhang L; Fang M; Zhou B; Tian W; Xu Y
    Biochim Biophys Acta; 2015 Sep; 1849(9):1219-28. PubMed ID: 26241940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MKL1 mediates TGF-β-induced CTGF transcription to promote renal fibrosis.
    Mao L; Liu L; Zhang T; Wu X; Zhang T; Xu Y
    J Cell Physiol; 2020 May; 235(5):4790-4803. PubMed ID: 31637729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling.
    Tian W; Fan Z; Li J; Hao C; Li M; Xu H; Wu X; Zhou B; Zhang L; Fang M; Xu Y
    Int J Biochem Cell Biol; 2016 Feb; 71():35-43. PubMed ID: 26693892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-autonomous role of MKL1 in the activation of hepatic stellate cells.
    Li Z; Li P; Lu Y; Sun D; Zhang X; Xu Y
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):609-618. PubMed ID: 30951901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension.
    Chen D; Yang Y; Cheng X; Fang F; Xu G; Yuan Z; Xia J; Kong H; Xie W; Wang H; Fang M; Gao Y; Xu Y
    Hypertension; 2015 Apr; 65(4):821-33. PubMed ID: 25646298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.
    Cheng X; Yang Y; Fan Z; Yu L; Bai H; Zhou B; Wu X; Xu H; Fang M; Shen A; Chen Q; Xu Y
    Oncogene; 2015 Oct; 34(44):5570-81. PubMed ID: 25746000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription.
    Li Z; Chen B; Dong W; Kong M; Fan Z; Yu L; Wu D; Lu J; Xu Y
    Cell Death Dis; 2019 Nov; 10(12):899. PubMed ID: 31776330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
    J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
    Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor (NF)-κB p65 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-β.
    Sun X; Chen E; Dong R; Chen W; Hu Y
    Life Sci; 2015 Feb; 122():8-14. PubMed ID: 25498897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.
    Lim JY; Oh MA; Kim WH; Sohn HY; Park SI
    J Cell Physiol; 2012 Mar; 227(3):1081-9. PubMed ID: 21567395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
    Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Smad3 in mediating mouse hepatic stellate cell activation.
    Schnabl B; Kweon YO; Frederick JP; Wang XF; Rippe RA; Brenner DA
    Hepatology; 2001 Jul; 34(1):89-100. PubMed ID: 11431738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells.
    Tian W; Hao C; Fan Z; Weng X; Qin H; Wu X; Fang M; Chen Q; Shen A; Xu Y
    J Hepatol; 2015 Jan; 62(1):165-74. PubMed ID: 25109772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
    Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
    Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.